Current status and future perspectives of rare disease research.

He, Cai-Hong; Jiang, Wan-Zi; Zhang, Li-Wen; Ruan, Mei-Hua; Zhou, Hong-Wen; Yu, Jian-Rong

He, Cai-Hong; Jiang, Wan-Zi; Zhang, Li-Wen; Ruan, Mei-Hua; Zhou, Hong-Wen; Yu, Jian-Rong.

Affiliation

He CH; Shanghai Information Center for Life Sciences, Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences, Shanghai 200031, China.
Jiang WZ; Chinese Academy of Sciences, Beijing 100049, China.
Zhang LW; Department of Endocrinology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029,China.
Ruan MH; Shanghai Information Center for Life Sciences, Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences, Shanghai 200031, China.
Zhou HW; Shanghai Information Center for Life Sciences, Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences, Shanghai 200031, China.
Yu JR; Department of Endocrinology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029,China.

Yi Chuan ; 43(6): 531-544, 2021 Jun 20.

Article in En | MEDLINE | ID: mdl-34284986

Subject(s)

Quality of Life; Rare Diseases; China; Gene Editing; Genetic Therapy; Humans; Rare Diseases/diagnosis; Rare Diseases/genetics; Rare Diseases/therapy

Key words

drug development; rare diseases; research status

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quality of Life / Rare Diseases Type of study: Diagnostic_studies / Prognostic_studies Aspects: Patient_preference Limits: Humans Country/Region as subject: Asia Language: En Journal: Yi Chuan Journal subject: GENETICA Year: 2021 Document type: Article Affiliation country: China Country of publication: China

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google